Antifungal once-a-day product, use and formulation thereof
First Claim
Patent Images
1. A once-a-day antifungal product comprising:
- first, second, and third dosage forms, wherein each of said dosage forms includes at least one antifungal agent and a pharmaceutically acceptable carrier;
said first dosage form is an immediate release dosage form;
said second and third dosage forms are delayed release dosage forms;
each of said first, second, and third dosage forms initiates release of said at least one antifungal agent at different times;
Cmax in serum of the total antifungal agent released from said antifungal product is achieved in less than about 12 hours from administration; and
said once-a-day antifungal product contains the total dosage of said at least one antifungal agent for a twenty-four hour period.
1 Assignment
0 Petitions
Accused Products
Abstract
An antifungal product is comprised of at least three dosages forms, each of which has a different release profile, with the Cmax for the antifungal product being reached in less than about twelve hours. In one embodiment, there is an immediate release dosage form, as well as two or more delayed release dosage forms, with each of the dosage forms having a different release profile, wherein each reaches a Cmax at different times.
352 Citations
45 Claims
-
1. A once-a-day antifungal product comprising:
- first, second, and third dosage forms, wherein each of said dosage forms includes at least one antifungal agent and a pharmaceutically acceptable carrier;
said first dosage form is an immediate release dosage form;
said second and third dosage forms are delayed release dosage forms;
each of said first, second, and third dosage forms initiates release of said at least one antifungal agent at different times;
Cmax in serum of the total antifungal agent released from said antifungal product is achieved in less than about 12 hours from administration; and
said once-a-day antifungal product contains the total dosage of said at least one antifungal agent for a twenty-four hour period. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 43, 44)
- first, second, and third dosage forms, wherein each of said dosage forms includes at least one antifungal agent and a pharmaceutically acceptable carrier;
-
41. A once-a-day antifungal product for oral administration comprising:
- first, second, and third dosage forms, wherein each of said dosage forms includes at least one antifungal agent and a pharmaceutically acceptable carrier;
said first dosage form is an immediate release dosage form;
said second and third dosage forms are delayed release dosage forms;
each of said first, second and third dosage forms initiates release of said at least one antifungal agent at different times;
Cmax in serum of the total antifungal agent released from said antifungal product is achieved in less than about 12 hours from administration; and
said once-a-day antifungal product contains the total dosage of said at least one antifungal agent for a twenty-four hour period. - View Dependent Claims (42, 45)
- first, second, and third dosage forms, wherein each of said dosage forms includes at least one antifungal agent and a pharmaceutically acceptable carrier;
Specification